Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022

New york, jan. 24, 2022 (globe newswire) -- mesoblast limited (nasdaq:meso; asx:msb), global leader in allogeneic cellular medicines for inflammatory diseases, announced today it is participating in edison group's open house event, scheduled to take place virtually this week. the three-day event, in association with london stock exchange, global law firm taylor wessing and openexchange, will take place between january 25-27th, focusing on 33 companies. mesoblast will feature on day one - businesses within pharmaceuticals & drug discovery.
MESO Ratings Summary
MESO Quant Ranking